Stockreport

Clovis Oncology's stock soars after FDA accepts sNDA for prostate cancer treatment [MarketWatch]

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF Clovis Oncology's stock soars after FDA accepts sNDA for prostate cancer treatment Shares of Clovis Oncology Inc. CLVS, +19.55% soared 22% in very active premarket tr [Read more]